STOCK TITAN

Andreas Bovopoulos Discloses 1.45M Shares (4.82%) in Cosmos Health (COSM)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Andreas Bovopoulos reported beneficial ownership of 1,453,044 shares of Cosmos Health Inc. common stock, representing 4.823% of the class. The filing is a Schedule 13G/A dated for the event on 08/13/2025 and signed 08/19/2025. Bovopoulos reports sole voting and dispositive power over all shares and certifies the shares were not acquired to influence control of the issuer. The issuer's principal executive office is listed in Thessaloniki, Greece. The disclosure classifies this holding as ownership of 5 percent or less of the class and indicates no group affiliation, no subsidiary acquisition, and no holdings on behalf of another person.

Positive

  • Complete disclosure of beneficial ownership (1,453,044 shares) and voting/dispositive powers
  • Position below 5% threshold, indicating a passive holding rather than a control attempt
  • No group affiliation or third-party holdings disclosed, reducing governance complexity

Negative

  • None.

Insights

TL;DR: A 4.823% single-investor stake disclosed; compliant, non-control position.

The filing shows an individual investor, Andreas Bovopoulos, beneficially owns 1,453,044 shares (4.823%) with sole voting and dispositive power. Classification under Schedule 13G/A and the certification language indicate the position is passive and not intended to change control. For investors, this is a material disclosure of a concentrated position below the 5% control threshold; it signals interest but not an activating stake. No related-party, group affiliations, or agent/nominee arrangements are reported, reducing governance complexity from this filing alone.

TL;DR: Disclosure suggests transparency and no immediate governance challenge to management.

The report confirms sole voting and dispositive authority but explicitly states the holding is not intended to influence control. Because the stake is under 5%, it falls within passive investor reporting norms and does not trigger mandatory takeover or control disclosures. The absence of group members or holdings on behalf of others simplifies the governance implications. This filing should be viewed as routine beneficial ownership reporting rather than a prelude to activist engagement.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Bovopoulos Andreas
Signature:Andreas Bovopoulos
Name/Title:Individual Investor
Date:08/19/2025

FAQ

What stake in Cosmos Health Inc. (COSM) does Andreas Bovopoulos report?

The filing reports 1,453,044 shares, representing 4.823% of Cosmos Health Inc. common stock.

Does this Schedule 13G/A indicate an attempt to control Cosmos Health Inc. (COSM)?

No. The filer certifies the securities were not acquired to change or influence control and the position is reported as passive.

Does Andreas Bovopoulos share voting or dispositive power over these shares?

No shared power is reported. The filing shows sole voting and sole dispositive power for all 1,453,044 shares.

Is the ownership reported on behalf of another person or a group?

No. The form states Not Applicable for holdings on behalf of another person and for group membership.

Where is Cosmos Health Inc.'s principal executive office listed in the filing?

The principal executive office is listed as 5 Agiou Georgiou, Pilea, Thessaloniki, Greece, 55438.
Cosmos Health Inc.

NASDAQ:COSM

COSM Rankings

COSM Latest News

COSM Latest SEC Filings

COSM Stock Data

20.23M
28.37M
28.16%
8.57%
1.46%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
THESSALONIKI